The phone rang just before midnight. It was early February in 2001 in Mumbai, and Yusuf Hamied, a seasoned chemist at the Indian multinational pharma company Cipla, was at a dinner party. He picked up ...

With Ozempic and Wegovy losing protection in key markets, Indian pharma majors gear up for launches that could sharply cut prices and expand access to diabetes and weight-loss therapy The world's ...

On any given morning in Mumbai’s Shivaji Park, power-walkers circle the running track, fitness watches buzzing with every step. Minutes later, some drift toward nearby food stalls, where oil sizzles ...

Until recently, Indians had few safe ways of joining the global craze for weight-loss drugs. Some smuggled them into the country when returning home from abroad; others chanced it with bootlegged ...

In 2026, Novo Nordisk’s patent on semaglutide will expire in several countries, including India and China. Generic-drug makers are poised to flood these markets with inexpensive products. Industry ...

WASHINGTON, D.C. (7News) — Thousands of miles away from the pharmacies we trust, Indian pharmaceutical companies produce the drugs that fill our medicine cabinets and hospitals. What happens inside ...

India's CDSCO ordered new safety warnings for Doxycycline (CNS issues like anxiety/dizziness) and Carbimazole (agranulocytosis risk) to improve patient safety and ADR awareness.

(Corrects headline and paragraph 1 in Feb 23 story to add dropped words, paragraph 6 to say the regulator did not specify the number of firms) By Rishika Sadam and Kashish Tandon MUMBAI, Feb 23 ...

Several Indian organisations are trying to block US firm Gilead’s patent claims, which they say will stop the medicine from ...

Israeli Defense Forces began another wave of strikes against Iran on Sunday after launching a joint strike with the U.S. by LISA FLETCHER, ANDREA NEJMAN and NATHAN AARON WASHINGTON — Our investigation ...